[Efforts to enhance the efficiency of tumor chemotherapy]

Area of Science:

• Oncology
• Pharmacology
• Biochemistry

Background:

• Cytotoxic agents, while vital in cancer treatment, often exhibit low selectivity, narrow therapeutic indices, and significant side effects, leading to resistance.
• Drug efficacy is influenced by patient-specific factors (age, gender, pharmacogenetics), tumor characteristics, and drug pharmacokinetics/pharmacodynamics.
• Investigating methods to enhance drug efficacy and minimize toxicity is crucial for improving patient outcomes in cancer therapy.

Discussion:

• Characterizing and mitigating the toxic side effects of cytotoxic agents is a primary research objective.
• Biochemical modulation strategies are employed to decrease toxicity and enhance the antitumor effects of 5-fluorouracil.
• Exploring individualized drug selection based on patient pharmacobiochemical and pharmacogenetic profiles is key to personalized medicine.

Key Insights:

• Developing strategies to mitigate toxic side effects of cytotoxic chemotherapy is essential.
• Biochemical modulation shows promise in improving the therapeutic index of agents like 5-fluorouracil.
• Pharmacogenetic and pharmacobiochemical profiling can guide individualized drug selection for cancer patients.

Outlook:

• Future research will focus on refining biochemical modulation techniques for broader application.
• Continued investigation into pharmacogenetics will enable more precise patient stratification for targeted therapies.
• The ultimate goal is to integrate these findings into clinical practice for enhanced cancer treatment personalization.